Web Results

law.justia.com/cases/federal/district-courts/pennsylvania/pawdce/2:2017cv01153/240814/20

Feb 15, 2018 ... BELL v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al, No. 2: 2017cv01153 - Document 20 (W.D. Pa. 2018) case opinion from ...

law.justia.com/cases/delaware/superior-court/2017/n16c-12-231-pra.html

Machala v. Boehringer Ingelheim Pharmaceuticals, Inc., et al.

www.law360.com/cases/55c120da7e21ae3645000003

... INC. et al v. HEC PHARM CO., LTD. et al, case number 3:15-cv-05982, from New Jersey Court. ... BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. ...... GREGORY D. MILLER, RIVKIN RADLER LLP TERMINATED: 03/16/ 2016.

www.law360.com/cases/59820bc59c43e06ea0000001

Parties, docket activity and news coverage of federal case AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, case number 1:17-cv-01065, from Delaware Court. ... Counter Claimant. Boehringer Ingelheim Pharmaceuticals, Inc.

www.ftc.gov/enforcement/cases-proceedings/091-0023/boehringer-ingelheim-pharmaceuticals-inc

Aug 21, 2017 ... Federal Trade Commission v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir.), Final Opening Brief of the Federal Trade Commission, ...

www.gpo.gov/fdsys/pkg/USCOURTS-njd-3_15-cv-05982/content-detail.html

Jan 5, 2017 ... 15-5982 - BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al.

www.linkedin.com/in/edwardpmiller

See the complete profile on LinkedIn and discover Edward's connections and ... Alexion Pharmaceuticals, Inc.,; Boehringer Ingelheim,; U.S. Department of Justice ... that met/exceeded all statutory and life sciences industry requirements at two ... Owner & CEO WGOJ E.T.'s Gospel of Jazz Radio Show Internet Radio Station.

www.kywd.uscourts.gov/sites/kywd/files/general-ordes/General_Order_2018-03_1.pdf

Boehringer Ingelheim Pharmaceuticals, Inc. et al ... 3:18-cv-00121-JHM-CHL Servpro Intellectual Property, Inc. et al v. ... 3:16-cv-00621-DJH-DW Miller v.

www.rug.nl/research/portal/files/50615255/1_s2.0_S0169500217304877_main.pdf

patients with EGFR mutation-positive non-small-cell lung cancer and acquired ... h Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, ...... [18] V.A. Miller, V. Hirsh, J. Cadranel, et al., Afatinib versus placebo for patients with.